43
4
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T78018 |
Plasminogen
|
||
Plasminogen是一种可由尿激酶血浆蛋白原激活剂(uPA)或组织血浆蛋白原激活剂(tPA)裂解激活的分泌性蛋白,生成血浆蛋白,该酶可以广泛裂解纤维蛋白及其他ECM成分。作为促炎调节剂,Plasminogen能促进急性及糖尿病相关伤口愈合。该蛋白在伤口愈合、炎症和低纤溶酶原血症的研究中有重要应用。 | |||
T13408 |
ZK824190
|
Others; Serine Protease | Others; Proteases/Proteasome |
ZK824190 是具有口服活性尿激酶型纤溶酶原激活剂 (uPA) 选择性抑制剂,对 uPA,tPA 和 Plasmin 的IC50分别为 237,1600 和 1850 nM。ZK824190在多发性硬化症中有研究价值。 | |||
T28788 |
SK-216
SK216.Plasminogen activator inhibitor-1 (PAI-1) inhibitor |
||
SK-216 is a specific PAI-1 inhibitor. SK-216 reduced the extent of angiogenesis in the tumors and inhibited VEGF-induced migration and tube formation by human umbilical vein endothelial cells in vitro. SK-216 reduced the degree of bleomycin-induced pulmon | |||
T8962 |
TM5007
|
PAI-1 | Metabolism |
TM5007 是纤溶酶原激活物抑制剂-1(PAI-1;IC50 为 29 uM)的强效抑制剂。 | |||
T4254 |
TM5441
|
PAI-1; Apoptosis | Apoptosis; Metabolism |
TM5441 是口服生物可利用的纤溶酶原激活物抑制剂-1 抑制剂,抑制多个癌症细胞系的 IC50值在 13.9 到 51.1 μM。它诱导几种人类癌症细胞的内在调亡,减弱 Nω-硝基-1-精氨酸甲酯诱导的心脏高血压和血管衰老。 | |||
T3442 |
UK-371804
UK371804 |
PAI-1; Serine Protease | Metabolism; Proteases/Proteasome |
UK-371804 是一种尿嘧啶型纤溶酶原激活物的抑制剂,Ki=10 nM。 | |||
T13257 |
Upamostat
|
PAI-1; Serine/threonin kinase; Serine Protease | Cell Cycle/Checkpoint; Metabolism; Proteases/Proteasome |
Upamostat 是一种丝氨酸蛋白酶抑制剂,也是一种具有口服活性的 WX-UK1 前药,是一种尿激酶型纤溶酶原激活剂 (uPA) 抑制剂。 | |||
T4255 |
TM5275 sodium
TM5275 sodium salt |
PAI-1 | Metabolism |
TM5275 sodium (TM5275 sodium salt) 是一种纤溶酶原激活物抑制剂,IC50=6.95 μM。 | |||
T2030 |
Tiplaxtinin
PAI-039,Tiplasinin |
PAI-1; Apoptosis | Apoptosis; Metabolism |
Tiplaxtinin (Tiplasinin) 是一种具有口服活性的选择性纤溶酶原激活物抑制剂-1 抑制剂,IC50为 2.7 μM。 | |||
T29856 |
Aleplasinin
PAZ 417,PAZ417,PAZ-417 |
PAI-1 | Metabolism |
Aleplasinin (PAZ 417) 是纤溶酶原激活物抑制剂 1 (PAI-1) 的选择性和口服活性抑制剂,是纤溶系统的关键负调节剂。 Aleplasinin 可用于阿尔茨海默病研究。 | |||
T8362 |
Benzamidine hydrochloride
Benzamidine HCl,苄脒盐酸盐 |
Serine/threonin kinase; Serine Protease | Cell Cycle/Checkpoint; Metabolism; Proteases/Proteasome |
Benzamidine hydrochloride (Benzamidine HCl) 是可逆的胰蛋白酶样丝氨酸蛋白酶 (trypsin-like serine proteases) 竞争性抑制剂,对 uPA、类胰蛋白酶、胰蛋白酶和 Xa 因子作用的Ki 分别为 97 µM、20 µM、21 µM 和 110 µM。 | |||
TP2338L |
Cenupatide acetate
Cenupatide acetate(1006388-38-0 Free base) |
Others | Others |
Cenupatide acetate 是一种尿激酶纤溶酶原激活物受体 (uPAR) 抑制剂,用于治疗与细胞迁移改变相关的疾病,例如癌症。 | |||
T3359 |
Aprotinin
抑酶肽,抑肽酶,Bovine Pancreatic Trypsin Inhibitor,Traskolan,Antilysin |
Others; Serine Protease; Influenza Virus; Proteasome | Microbiology/Virology; Others; Proteases/Proteasome; Ubiquitination |
Aprotinin (Traskolan) 是分离自牛肺的一种广谱丝氨酸蛋白酶抑制剂,可抑制多种不同酯酶和蛋白酶的活性。 | |||
T60248 |
4-Aminobenzamidine dihydrochloride
p-Aminobenzamidine dihydrochloride |
Serine Protease | Proteases/Proteasome |
4-Aminobenzamidine dihydrochloride (p-Aminobenzamidine dihydrochloride) 是一种强胰蛋白酶 (trypsin)抑制剂,也是一种相对较弱的尿激酶型纤溶酶原激活剂 (uPA) 抑制剂 (Ki=82 μM)。4-Aminobenzamidine 可抑制 SCID 小鼠体内前列腺肿瘤的生长。 | |||
T71851 |
5-trans-Prostaglandin E2
|
||
5-trans-Prostaglandin E2 accelerates fibrinolysis by enhancing plasminogen activation mediated by tissue-type plasminogen activator. It also inhibits platelet aggregation in human PRP. | |||
T13251 |
UKI-1
UKI-1C |
Others | Others |
UKI-1 is a urokinase-type plasminogen activator system synthetic inhibitor. | |||
T70734 |
U46,195
|
||
U46,195 stimulates the production of tissue-type plasminogen activator, and is a PAF antagonist. | |||
T70417 |
XR 1853
|
||
XR 1853 is a low molecular weight modulator of human plasminogen activator inhibitor-1 activity. | |||
T69751 |
UK-356202
|
||
UK-356,202 is a potent and selective urokinase-type plasminogen activator (Ki = 37 nM). Urokinase plasminogen activator (uPA, urokinase) is a trypsinlike serine protease and a therapeutical target for many cancer types, including breast, ovarian, and pancreatic cancer. uPA is a valuable oncology target. | |||
T68572 | IMD-1622 | ||
IMD-1622 is a plasminogen activator inhibitor-1 (PAI-1) inhibitor. | |||
T69890 |
PS-519
|
||
PS-519 is a human tissue plasminogen activator and proteasome inhibitor. | |||
T68659 |
Valyl-glycyl-arginine-4-nitroanilide
|
||
Valyl-glycyl-arginine-4-nitroanilide is a tissue plasminogen activator. | |||
T69319 |
U 34599
|
||
U 34599 stimulates the production of tissue-type plasminogen activator. | |||
T25915 |
Diaplasinin
PAI-749,PAI749,PAI 749 |
||
PAI-749 is a selective and effective antagonist agent of plasminogen activator inhibitor 1 (PAI-1). | |||
T13409L |
ZK824859 hydrochloride (2271122-53-1 free base)
ZK824859 hydrochloride |
Others | Others |
ZK824859 hydrochloride is an oral available and selective inhibitor of urokinase plasminogen activator (uPA)(IC50s of 79 nM, 1580 nM and 1330 nM for human uPA, tPA, and plasmin, respectively). | |||
T70927 |
UCD74A HCl
|
||
UCD74A HCl is a cell impermeant homolog of UCD38B, inhibitor of uPA (urokinase plasminogen activator). | |||
T13409 | ZK824859 | Others | Others |
ZK824859 is an oral available and selective inhibitor of urokinase plasminogen activator (uPA)(IC50s of 79 nM, 1580 nM and 1330 nM for human uPA, tPA, and plasmin, respectively). | |||
T41085 |
UK122
UK122 |
||
UK122 is a highly effective and specific inhibitor of urokinase-type plasminogen activator (uPA) with an IC50 value of 0.2 μM. It displays negligible to minimal inhibition towards tissue-type plasminogen activator (tPA), plasmin, thrombin, and trypsin (all IC50 >100 μM). Functioning as a 4-oxazolidinone analogue, UK122 is an anticancer agent that effectively inhibits cancer cell migration and invasion. | |||
T70810 |
THR-18
|
||
THR-18 is an 18-mer peptide derived from the sequence of human plasminogen activator inhibitor 1 (PAI-1), having the ability to bind to a site of tissue plasminogen activator (tPA) distal to its catalytic site and uncouple the beneficial clot-dissolving properties of tPA from its deleterious non-fibrinolytic effects. | |||
T41029 |
Streptokinase
|
||
Streptokinase is a bacterial protein that acts as a plasminogen activator, commonly employed in the investigation of blood-clotting disorders. Its application extends to enhancing reperfusion blood flow after coronary artery occlusion. | |||
T68682 |
Piriprost
|
||
Piriprost is a leukotriene inhibitor attenuates the smoke-induced increase in alveolar-capillary barrier permeability and decrease in plasminogen activator activity and causes a swelling of type I alveolar epithelium. | |||
T72113 |
6-Aminocaproic acid hydrochloride
EACA hydrochloride,EACA hydrochloride ; Epsilon-Amino-n-caproic Acid hydrochloride ; 6-Aminohexanoic acid hydrochloride,6-Aminohexanoic acid hydrochloride,Epsilon-Amino-n-caproic Acid hydrochloride |
||
6-Aminocaproic acid hydrochloride,一种单氨基羧酸,作为有效及口服活性的纤溶酶和纤溶酶原抑制剂,具备显著的抗纤溶能力。通过竞争性结合纤溶酶原上的赖氨酸残基,6-Aminocaproic acid hydrochloride 阻止血块溶解,抑制纤溶酶生成,减少纤维蛋白溶解,用于出血性疾病研究。 | |||
T35931 |
GGACK (hydrochloride)
|
||
GGACK is an inhibitor of urokinase-type plasminogen activator (uPA) and factor Xa (Kis = 1.8 and 8.7 μM, respectively).1,2 1.Kettner, C., and Shaw, E.The susceptibility of urokinase to affinity labeling by peptides of arginine chloromethyl ketoneBiochim. Biophys. Acta569(1)31-40(1979) 2.Kettner, C., and Shaw, E.The selective affinity labeling of factor Xa by peptides of arginine chloromethyl ketoneThromb. Res.22(5-6)645-652(1981) | |||
T73701 |
Urokinase (peptidolytic)
|
||
Urokinase peptidolytic (Urokinase-type plasminogen activator) 是一种丝氨酸蛋白酶,是丝氨酸蛋白酶纤溶酶的一种非活性形式(酶原)。纤溶酶的激活可触发蛋白水解级联反应,进而参与血栓溶解或细胞外基质降解,涉及血管疾病和癌症相关研究。 | |||
TP2338 |
Cenupatide
UPARANT,Cenupatide trifluoroacetic acid salt,Ac-Arg-Aib-Arg-α(Me)Phe-NH2) |
||
Cenupatide is a urokinase plasminogen activator receptor (uPAR) inhibitor. Cenupatide inhibits uPAR binding to the formyl peptide receptors (FPRs) can improve kidney lesions in a rat model of STZ-induced diabetes. Cenupatide reverted STZ-induced up-regula | |||
T40614 |
LCKLSL
|
||
LCKLSL, an N-terminal hexapeptide, acts as a competitive inhibitor of annexin A2 (AnxA2), effectively preventing the binding of tissue plasminogen activator (tPA) to AnxA2 while also inhibiting the generation of plasmin. In addition, LCKLSL exhibits anti-angiogenic properties. | |||
T11152 |
Edaravone-d5
MCI-186 D5 |
Others | Others |
Edaravone, a novel and potent free radical scavenger, effectively prevents MMP-9-related brain hemorrhage in rats treated with tissue plasminogen activator. Its deuterium-labeled variant, Edaravone D5, retains the original compound's attributes while offering isotopic labeling benefits. | |||
T80859 |
Vitronectin
|
||
Vitronectin为一类多功能糖蛋白,广泛分布于血液及细胞外基质。该蛋白质与糖胺聚糖、胶原蛋白、纤溶酶原及尿激酶受体发生结合,并对纤溶酶原激活抑制剂1的抑制构象起稳定作用。Vitronectin常用于促进伤口愈合和肿瘤进展研究领域。 | |||
T80736 |
Z-Gly-Gly-Arg-AFC
|
||
Z-Gly-Gly-Arg-AFC为具有生物活性的肽类化合物,属于(纤溶酶原激活剂顶体碱底物,荧光Z-Gly-Gly-Arg-AFC)。 | |||
T68513 |
BSc2118
|
||
BSc2118 is a potent proteasome inhibitor. BSc2118 shows significant antimyeloma activity and may be considered as a promising agent in cancer drug development. BSc2118 is also a promising new candidate for stroke therapy, which may in addition alleviate recombinant tissue-plasminogen activator-induced brain toxicity. | |||
TP2482 |
LCKLSL acetate
LCKLSL acetate(533902-29-3 free base) |
Annexin A | GPCR/G Protein |
LCKLSL acetate 是一种竞争性膜联蛋白 A2 (AnxA2) 抑制剂。 LCKLSL acetate 有效抑制组织纤溶酶原激活剂 (tPA) 与 AnxA2 的结合和纤溶酶的产生。 LCKLSL acetate 具有抗血管生成作用。 | |||
T64287 |
Reteplase
|
||
Reteplase (BM 06.022) 是一种重组纤溶酶原 (plasminogen) 激活剂,由人组织型纤溶酶原激活剂的 kringle 2 和蛋白酶结构域构成。Reteplase 能够将纤溶酶原转化为纤溶酶,促使血栓溶解。Reteplase 通过 DNA 技术在大肠杆菌中产生的 t-PA 突变体,未糖基化。 | |||
T78015 |
LCKLSL hydrochloride
|
||
LCKLSL hydrochloride为N端六肽,作为膜联蛋白A2(AnxA2)的竞争性抑制剂,有效阻止组织纤溶酶原激活物(tPA)与AnxA2结合。此化合物还能够抑制纤溶酶生成,并表现出抗血管生成活性。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3876 |
Loureirin B
龙血素B,龙血素 B |
PAI-1; ERK; Potassium Channel; JNK | MAPK; Membrane transporter/Ion channel; Metabolism |
Loureirin B 是从剑叶龙血树中分离到的一种黄酮,是 PAI-1抑制剂,IC50值为 26.10 μM。它抑制 KATP,以及 ERK 和 JNK 的磷酸化,具有抗糖尿病的功效。 | |||
T4S0592 |
Toddalolactone
(+)-Toddalolactone,飞龙掌血内酯,毛两面针素 |
PAI-1 | Metabolism |
Toddalolactone ((+)-Toddalolactone) 是一种Toddalia asiatica 的主要成分,能够抑制重组人纤溶酶原激活物抑制物-1(PAI-1)的活性, IC50=37.31 μM。 | |||
T0881 |
6-Aminocaproic acid
氨基己酸,EACA,6-氨基己酸,6-Aminohexanoic acid,Epsilon-Amino-n-caproic Acid,(6-)ε-Aminocaproic acid |
Others | Others |
6-Aminocaproic acid (EACA) 是一种单氨基羧酸,是一种有效的、具有口服活性的纤溶酶和纤溶酶原的抑制剂。它是一种有效的抗纤维蛋白溶解剂,能够竞争性结合纤溶酶原上的赖氨酸残基,防止血块溶解,并抑制纤溶酶的形成,减少纤维蛋白溶解。它可用于出血性疾病的研究。 | |||
T6S1699 |
Shogaol
[6]-Shogaol,姜烯酚,6-姜烯酚,6-Shogaol |
Lipoxygenase; Autophagy | Autophagy; Metabolism |
6-Shogaol (6-Shogaol) 是从生姜中分离的一种天然产物,具有抗癌、抗炎和抗氧化的多种生物活性。 |